Cargando…
A new therapeutic strategy for lung tissue injury induced by influenza with CR2 targeting complement inhibitior
BACKGROUND: Influenza is a respiratory disease that seriously threatens human health. In fact, influenza virus itself does not make critical contribution to mortality induced by influenza, but "cytokine storm" produced by the excessive immune response triggered by the virus can result in i...
Autores principales: | Zhang, Chuanfu, Xu, Yuanyong, Jia, Leili, Yang, Yutao, Wang, Yong, Sun, Yansong, Huang, Liuyu, Qiao, Fei, Tomlinson, Stephen, Liu, Xuelin, Zhou, Yusen, Song, Hongbin |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829536/ https://www.ncbi.nlm.nih.gov/pubmed/20144216 http://dx.doi.org/10.1186/1743-422X-7-30 |
Ejemplares similares
-
A novel approach to inhibit HIV-1 infection and enhance lysis of HIV by a targeted activator of complement
por: Xu, Yuanyong, et al.
Publicado: (2009) -
A new treatment for neurogenic inflammation caused by EV71 with CR2-targeted complement inhibitor
por: Qiu, Shaofu, et al.
Publicado: (2012) -
A novel trifunctional IgG-like bispecific antibody to inhibit HIV-1 infection and enhance lysis of HIV by targeting activation of complement
por: Jia, Leili, et al.
Publicado: (2010) -
Complement controls the immune synapse and tumors control complement
por: Herbert, Alan
Publicado: (2020) -
Screening of Human Antibody Fab Fragment against HBsAg and the Construction of its dsFv Form
por: Jia, Leili, et al.
Publicado: (2008)